Piramal Pharma Solutions expands sterile manufacturing facility in US

The company to invest $25 mn to expand its manufacturing capability in phases

Premium

Rakesh Rao Mumbai

Last Updated : Mar 23 2017 | 10:40 AM IST

Piramal Pharma Solutions (PPS), a part of Piramal Group that is engaged in contract development and manufacturing, has expanded the manufacturing capabilities of its Lexington (Kentucky, USA) facility.

PPS develops and manufactures sterile finished dosage forms at the Lexington site using the state of the art Isolator technology. The $25 million investment, which increases Piramal’s capacity and capabilities in manufacturing, is being rolled out in phases.

Phase-I, which is now complete, includes the installation of a new high-speed vial filling line, expansion of the state-of-the art laboratories, and associated utility support. The new filling line will double the capacity at Lexington, while

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in